cp wire

CP Wire Articles

Novartis' Siponimod significantly improved outcomes in PhIII data published in Lancet

Novartis announced Thursday that the full results from the Phase III EXPAND study of oral, once-daily siponimod (BAF312) in secondary progressive multiple sclerosis (SPMS) were published in the... read more

Fri, 03/23/18 - 12:47 am
Allergan - Forest gender discrimination $4 million settlement final date approaching

In July of 2012, Sanford Heisler Sharp, LLP filed a gender discrimination lawsuit against Forest Labs (now part of Allergan), on behalf of eleven female sales reps, as well as... read more
Thu, 03/22/18 - 03:44 pm
Healthcare on the Hill - House Passes "Right to Try" on Second Attempt

The House passed the so called “Right to Try” bill on Wednesday evening. The vote was roughly along party lines, 267-149 with 35 Democrats supporting the bill and 2 Republicans opposed.

... read more

Thu, 03/22/18 - 09:15 am
Positive Clinical Safety Results for AOBiome's Microbiome-Targeted Therapy for Intranasal Delivery

AOBiome Therapeutics today  announced clinical findings from Part 1 of a Phase 1b/2a clinical trial of the Company's first-in-class Ammonia Oxidizing Bacteria (AOB) product candidate for... read more

Wed, 03/21/18 - 10:07 am
Sun Pharma Receives Approval for New Plaque Psoriasis Drug

Sun Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved ILUMYA™ (tildrakizumab-asmn) for the treatment of adults with moderate-to-severe plaque psoriasis who are... read more

Wed, 03/21/18 - 09:44 am

Pages